Industries
Drug Delivery Systems
Drug delivery companies extend the therapeutic window and improve bioavailability of existing and novel APIs through lipid nanoparticles, polymer hydrogels, inhalation devices, and targeted delivery platforms. University pharmaceutical sciences departments are prolific IP generators for oral bioavailability enhancement, mucosal delivery, and brain-targeted carriers.
Details
- Companies
- CatalentLonza Drug DeliveryVectura HaleonNovaBay PharmaceuticalsBend ResearchCapsugel LonzaParticle SciencesEvonik Drug DeliveryLubrizol PharmaNuvax Pharma
- Market Size
- $210B
- Target Researchers
- Pharmaceutical scientists, chemical engineers, and biophysicists specializing in nanoparticle formulation, lipid-based delivery, polymer matrices, inhalation, transdermal, and implantable systems
- Use Cases
- Lipid nanoparticle formulation licensingInhalation device technology transferControlled-release polymer IP licensingSolubility enhancement consultingBioavailability improvement partnershipsCDMO formulation services